Drug-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Hemodialysis Fistulae: A Randomized Controlled Trial

CONCLUSIONS: AcoArt Orchid DCB showed better primary patency rates compared with plain balloon angioplasty for treating stenotic lesions in dysfunctional hemodialysis AV fistulae at 6 and 12 months. It required fewer repeated interventions and had comparable safety in 1 year.CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: AcoArt III/Arterio-venous Fistula in China, NCT03366727.PMID:38191561 | DOI:10.2215/CJN.0000000000000359

Source: Clinical Journal of the American Society of Nephrology : CJASN - January 8, 2024 Category: Urology & Nephrology Authors: Yiping Zhao Pei Wang Yuzhu Wang Lihong Zhang Yu Zhao Hua Li Qiang He Hao Liu Jianfang Luo Xin Jia Zhengya Yu Wei Guo Lan Zhang Source Type: research